Virtus ETF Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67K | Hold |
3,107
| – | – | 0.09% | 183 |
|
|
2025
Q1 | $51.6K | Sell |
3,107
-17,151
| -85% | -$285K | 0.07% | 200 |
|
|
2024
Q4 | $372K | Sell |
20,258
-1,568
| -7% | -$28.8K | 0.15% | 192 |
|
|
2024
Q3 | $336K | Hold |
21,826
| – | – | 0.16% | 220 |
|
|
2024
Q2 | $355K | Buy |
21,826
+8,247
| +61% | +$134K | 0.17% | 193 |
|
|
2024
Q1 | $251K | Buy |
13,579
+1,954
| +17% | +$36.1K | 0.13% | 232 |
|
|
2023
Q4 | $364K | Sell |
11,625
-980
| -8% | -$30.7K | 0.23% | 181 |
|
|
2023
Q3 | $263K | Sell |
12,605
-1,630
| -11% | -$34K | 0.16% | 219 |
|
|
2023
Q2 | $341K | Sell |
14,235
-5,285
| -27% | -$127K | 0.2% | 166 |
|
|
2023
Q1 | $367K | Buy |
19,520
+347
| +2% | +$6.53K | 0.2% | 159 |
|
|
2022
Q4 | $305K | Buy |
19,173
+4,680
| +32% | +$74.5K | 0.16% | 257 |
|
|
2022
Q3 | $237K | Buy |
14,493
+213
| +1% | +$3.48K | 0.09% | 296 |
|
|
2022
Q2 | $201K | Sell |
14,280
-1,892
| -12% | -$26.6K | 0.07% | 312 |
|
|
2022
Q1 | $392K | Hold |
16,172
| – | – | 0.18% | 153 |
|
|
2021
Q4 | $377K | Sell |
16,172
-613
| -4% | -$14.3K | 0.14% | 172 |
|
|
2021
Q3 | $279K | Sell |
16,785
-1,545
| -8% | -$25.7K | 0.12% | 207 |
|
|
2021
Q2 | $447K | Buy |
18,330
+6,326
| +53% | +$154K | 0.18% | 183 |
|
|
2021
Q1 | $310K | Buy |
12,004
+329
| +3% | +$8.5K | 0.13% | 237 |
|
|
2020
Q4 | $624K | Sell |
11,675
-1,073
| -8% | -$57.3K | 0.26% | 100 |
|
|
2020
Q3 | $526K | Buy |
12,748
+1,074
| +9% | +$44.3K | 0.28% | 128 |
|
|
2020
Q2 | $566K | Sell |
11,674
-1,602
| -12% | -$77.7K | 0.27% | 129 |
|
|
2020
Q1 | $561K | Sell |
13,276
-1,120
| -8% | -$47.3K | 0.23% | 162 |
|
|
2019
Q4 | $616K | Sell |
14,396
-14,167
| -50% | -$606K | 0.1% | 185 |
|
|
2019
Q3 | $1.03M | Sell |
28,563
-4,804
| -14% | -$173K | 0.21% | 149 |
|
|
2019
Q2 | $892K | Buy |
+33,367
| New | +$892K | 0.19% | 156 |
|
|
2016
Q4 | – | Sell |
-15,878
| Closed | -$505K | – | 176 |
|
|
2016
Q3 | $505K | Buy |
15,878
+2,001
| +14% | +$63.6K | 0.24% | 72 |
|
|
2016
Q2 | $450K | Buy |
13,877
+6,520
| +89% | +$211K | 0.33% | 64 |
|
|
2016
Q1 | $206K | Sell |
7,357
-457
| -6% | -$12.8K | 0.28% | 78 |
|
|
2015
Q4 | $279K | Buy |
+7,814
| New | +$279K | 0.77% | 42 |
|